Optimization of circulating biomarkers of obatoclax-induced cell death in patients with small cell lung cancer.
about
Pharmacodynamic modelling of biomarker data in oncology.The interconnectedness of cancer cell signaling.A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancerMulti-level evidence that circulating CK18 is a biomarker of tumour burden in colorectal cancer.Obatoclax impairs lysosomal function to block autophagy in cisplatin-sensitive and -resistant esophageal cancer cellsResistance to BH3 mimetic S1 in SCLC cells that up-regulate and phosphorylate Bcl-2 through ERK1/2.Cancer subclonal genetic architecture as a key to personalized medicine.Emerging drugs for small cell lung cancer--an update.Small molecules as pro-apoptotic anticancer agents.Monitoring apoptosis and Bcl-2 on circulating tumor cells in patients with metastatic breast cancer.Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integration
P2860
Q34241935-C8846EB6-DA9E-4361-BF6A-583E0DE4058FQ35669733-FDF89E0A-AC1E-41C3-BC00-C9E17641C92FQ35835203-9C46B1F6-6014-4E5B-AF79-F70065A13F10Q36385291-6D8165A7-BF4E-4DB1-9661-A4322F71CBE2Q37046690-259098FD-4C31-4BFB-970F-A093D949DB49Q37046792-058F4091-0E73-409F-85BB-7D2737FBDED0Q37448116-9CBADF29-DECE-4D6B-934B-1CA4D1D857D6Q37979856-1402C8A8-85DD-42E4-98B7-5F5F94C47E5AQ38162939-F5598813-780C-4E78-8E76-A695745F458FQ41134672-9B829D78-4773-40A2-9837-C8C6BEE47B19Q41879186-5B9BB9E2-78CB-4728-915F-FC0FEF3BEBBE
P2860
Optimization of circulating biomarkers of obatoclax-induced cell death in patients with small cell lung cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Optimization of circulating bi ...... s with small cell lung cancer.
@ast
Optimization of circulating bi ...... s with small cell lung cancer.
@en
Optimization of circulating bi ...... s with small cell lung cancer.
@nl
type
label
Optimization of circulating bi ...... s with small cell lung cancer.
@ast
Optimization of circulating bi ...... s with small cell lung cancer.
@en
Optimization of circulating bi ...... s with small cell lung cancer.
@nl
prefLabel
Optimization of circulating bi ...... s with small cell lung cancer.
@ast
Optimization of circulating bi ...... s with small cell lung cancer.
@en
Optimization of circulating bi ...... s with small cell lung cancer.
@nl
P2093
P2860
P50
P356
P1433
P1476
Optimization of circulating bi ...... s with small cell lung cancer.
@en
P2093
Anne Roulston
Jeff Cummings
Malcolm Ranson
Mark Berger
P2860
P304
P356
10.1593/NEO.101524
P577
2011-04-01T00:00:00Z